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**This article has been corrected:** The authors submitted the wrong Figure 5 (panel F) from other experiment group in this study and requested to replace it. The correct Figure 5 is provided below. The authors declare that this correction does not change the results or conclusions of this paper. The authors sincerely apologize for this error.

![**USP4 activated TGF-β signaling pathway to induce epithelial-to-mesenchymal transition (EMT).** (**A**) The expression of EMT markers in SK-Hep1- shRNA/USP4 cells and in negative control cells (\* P \< 0.05, \*\* P \< 0.01, \*\*\* P \< 0.001). (**B**) The expression of EMT markers in HuH7-USP4 cells and in negative control cells (\* P \< 0.05, \*\*\* P \< 0.001). (**C**) The expression of TGFR-1 and p-Smad2 in SK-Hep1- shRNA/USP4 cells and in negative control cells (\*\*\* P \< 0.001). (**D**) The expression of TGFR-1 and p-Smad2 in HuH7-USP4 cells and in negative control cells (\* P \< 0.05, \*\* P \< 0.01). (**E**) The expression of TGFR-1, p-Smad2 and EMT markers in SK-Hep1- shRNA/USP4 cells or in negative control cells, with TGF-β1(10ng/mL)treatment for 24h or without (\* P \< 0.05, \*\* P \< 0.01, \*\*\* P \< 0.001). (**F**) The migration ability of SK-Hep1-shRNA/USP4 cells or negative control cells, with TGF-β1 treatment or without, detected by Transwell migration assay (\*\* P \< 0.01, \*\*\* P \< 0.001).](aging-11-102010-g001){#f5}
